Taoshan Jiang
1Patents
0h-index
12Co-inventors
23Inventor score
Filing activity: Dec 15, 2016 → Dec 15, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10350210B2 | EGFR and ALK dual inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.